These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 31684693

  • 21. Magnesium for treating sickle cell disease.
    Than NN, Soe HHK, Palaniappan SK, Abas AB, De Franceschi L.
    Cochrane Database Syst Rev; 2017 Apr 14; 4(4):CD011358. PubMed ID: 28409830
    [Abstract] [Full Text] [Related]

  • 22. Drugs for preventing red blood cell dehydration in people with sickle cell disease.
    Nagalla S, Ballas SK.
    Cochrane Database Syst Rev; 2018 Oct 19; 10(10):CD003426. PubMed ID: 30338520
    [Abstract] [Full Text] [Related]

  • 23. Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease.
    Knight-Madden JM, Hambleton IR.
    Cochrane Database Syst Rev; 2022 Dec 02; 12(12):CD003733. PubMed ID: 36458811
    [Abstract] [Full Text] [Related]

  • 24. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).
    Wang WC, Ware RE, Miller ST, Iyer RV, Casella JF, Minniti CP, Rana S, Thornburg CD, Rogers ZR, Kalpatthi RV, Barredo JC, Brown RC, Sarnaik SA, Howard TH, Wynn LW, Kutlar A, Armstrong FD, Files BA, Goldsmith JC, Waclawiw MA, Huang X, Thompson BW, BABY HUG investigators.
    Lancet; 2011 May 14; 377(9778):1663-72. PubMed ID: 21571150
    [Abstract] [Full Text] [Related]

  • 25. Folate supplementation in people with sickle cell disease.
    Dixit R, Nettem S, Madan SS, Soe HHK, Abas AB, Vance LD, Stover PJ.
    Cochrane Database Syst Rev; 2018 Mar 16; 3(3):CD011130. PubMed ID: 29546732
    [Abstract] [Full Text] [Related]

  • 26. Phytomedicines (medicines derived from plants) for sickle cell disease.
    Oniyangi O, Cohall DH.
    Cochrane Database Syst Rev; 2015 Apr 06; (4):CD004448. PubMed ID: 25844571
    [Abstract] [Full Text] [Related]

  • 27. Phytomedicines (medicines derived from plants) for sickle cell disease.
    Oniyangi O, Cohall DH.
    Cochrane Database Syst Rev; 2020 Sep 25; 9(9):CD004448. PubMed ID: 32977351
    [Abstract] [Full Text] [Related]

  • 28. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 29. Drugs for preventing red blood cell dehydration in people with sickle cell disease.
    Singh PC, Ballas SK.
    Cochrane Database Syst Rev; 2007 Oct 17; (4):CD003426. PubMed ID: 17943791
    [Abstract] [Full Text] [Related]

  • 30. Drugs for preventing red blood cell dehydration in people with sickle cell disease.
    Nagalla S, Ballas SK.
    Cochrane Database Syst Rev; 2016 Mar 04; 3():CD003426. PubMed ID: 26942338
    [Abstract] [Full Text] [Related]

  • 31. Piracetam for reducing the incidence of painful sickle cell disease crises.
    Al Hajeri A, Fedorowicz Z.
    Cochrane Database Syst Rev; 2016 Feb 12; 2(2):CD006111. PubMed ID: 26869149
    [Abstract] [Full Text] [Related]

  • 32. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.
    Fisher SA, Brunskill SJ, Doree C, Gooding S, Chowdhury O, Roberts DJ.
    Cochrane Database Syst Rev; 2013 Aug 21; 2013(8):CD004450. PubMed ID: 23963793
    [Abstract] [Full Text] [Related]

  • 33. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.
    Estcourt LJ, Malouf R, Trivella M, Fergusson DA, Hopewell S, Murphy MF.
    Cochrane Database Syst Rev; 2017 Jan 27; 1(1):CD011305. PubMed ID: 28128441
    [Abstract] [Full Text] [Related]

  • 34. Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders.
    Gu Y, Estcourt LJ, Doree C, Hopewell S, Vyas P.
    Cochrane Database Syst Rev; 2015 Oct 05; 2015(10):CD011577. PubMed ID: 26436602
    [Abstract] [Full Text] [Related]

  • 35. Inhaled nitric oxide for treating pain crises in people with sickle cell disease.
    Aboursheid T, Albaroudi O, Alahdab F.
    Cochrane Database Syst Rev; 2022 Jul 08; 7(7):CD011808. PubMed ID: 35802341
    [Abstract] [Full Text] [Related]

  • 36. The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation.
    Cherry MG, Greenhalgh J, Osipenko L, Venkatachalam M, Boland A, Dundar Y, Marsh K, Dickson R, Rees DC.
    Health Technol Assess; 2012 Jul 08; 16(43):1-129. PubMed ID: 23140544
    [Abstract] [Full Text] [Related]

  • 37. Blood transfusions for treating acute chest syndrome in people with sickle cell disease.
    Alhashimi D, Fedorowicz Z, Alhashimi F, Dastgiri S.
    Cochrane Database Syst Rev; 2010 Jan 20; (1):CD007843. PubMed ID: 20091653
    [Abstract] [Full Text] [Related]

  • 38. Hematopoietic stem cell transplantation for people with sickle cell disease.
    Oringanje C, Nemecek E, Oniyangi O.
    Cochrane Database Syst Rev; 2020 Jul 03; 7(7):CD007001. PubMed ID: 32617981
    [Abstract] [Full Text] [Related]

  • 39. Prophylactic versus selective blood transfusion for sickle cell disease in pregnancy.
    Okusanya BO, Oladapo OT.
    Cochrane Database Syst Rev; 2016 Dec 22; 12(12):CD010378. PubMed ID: 28005272
    [Abstract] [Full Text] [Related]

  • 40. Blood transfusion for preventing stroke in people with sickle cell disease.
    Riddington C, Wang W.
    Cochrane Database Syst Rev; 2002 Dec 22; (1):CD003146. PubMed ID: 11869654
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.